2020
DOI: 10.1002/cmdc.202000271
|View full text |Cite|
|
Sign up to set email alerts
|

Identification of Adenosine Deaminase Inhibitors by Metal‐binding Pharmacophore Screening

Abstract: Adenosine deaminase (ADA) is a human mononuclear Zn 2 + metalloenzyme that converts adenosine to inosine. ADA is a validated drug target for cancer, but there has been little recent work on the development of new therapeutics against this enzyme. The lack of new advancements can be partially attributed to an absence of suitable assays for high-throughput screening (HTS) against ADA. To facilitate more rapid drug discovery efforts for this target, an in vitro assay was developed that utilizes the enzymatic conv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 38 publications
0
5
1
Order By: Relevance
“…The fenugreek QUE acts as a non-competitive inhibitor with a K i value of 55.5 mM. Moreover, the K i result is novel because there is no evidence in the literatures to compare the results with however, some studies are not consistent with our results (Singh and Sharma 2000 ; Adamek et al 2020 ; Kumar and Sharanya 2020 ; Kutryb-Zajac et al 2020 ). Thus, our results indicated that Egyptian Fenugreek QUE may act as a natural inhibitor of ADA which is a key inflammatory enzyme.…”
Section: Discussioncontrasting
confidence: 54%
“…The fenugreek QUE acts as a non-competitive inhibitor with a K i value of 55.5 mM. Moreover, the K i result is novel because there is no evidence in the literatures to compare the results with however, some studies are not consistent with our results (Singh and Sharma 2000 ; Adamek et al 2020 ; Kumar and Sharanya 2020 ; Kutryb-Zajac et al 2020 ). Thus, our results indicated that Egyptian Fenugreek QUE may act as a natural inhibitor of ADA which is a key inflammatory enzyme.…”
Section: Discussioncontrasting
confidence: 54%
“…The preparation of multiple emissive ADA substrates (Figure ), displaying distinct MM kinetics and photophysical parameters, facilitated the fabrication of a high-throughput assay for discovering inhibitors for this zinc enzyme . In collaboration with Seth Cohen’s laboratory, Paul Ludford had screened >300 metal-binding pharmacophores, identifying novel inhibitory motifs . In addition to metabolic A to I deamination, mRNA editing and tRNA maturation via adenosine deaminases acting on RNAs (ADARs) and adenosine deaminases acting on tRNAs (ADATs) involve similar transformations in distinct oligomeric contexts.…”
Section: Emissive Rna Alphabetsmentioning
confidence: 99%
“… 57 In collaboration with Seth Cohen’s laboratory, Paul Ludford had screened >300 metal-binding pharmacophores, identifying novel inhibitory motifs. 58 In addition to metabolic A to I deamination, mRNA editing and tRNA maturation via adenosine deaminases acting on RNAs (ADARs) and adenosine deaminases acting on tRNAs (ADATs) involve similar transformations in distinct oligomeric contexts. With Peter Beal, we evaluated the reactivity of ADAR2 with the th A-modified GluR B mRNA R/G editing site.…”
Section: Emissive Rna Alphabetsmentioning
confidence: 99%
“…We have advanced two emissive RNA alphabets, based on thieno­[3,4- d ]­pyrimidine (1st generation; th N ) and isothiazole­[4,3- d ]­pyrimidine (2nd generation; tz N ) heterocyclic cores (Figure a). The emissive adenosine analogs have been successfully used to advance real-time activity and inhibition assays of adenosine deaminase, exploiting the distinct emission profiles of the substrates ( th A and tz A ), and their corresponding deamination products ( th I and tz I , respectively), with the latter ( tz A ) being essentially isofunctional (Figure b). , The red-shifted absorption and visible-range emission of such fluorescent substrate surrogates opens a spectral window not accessible by other means, which facilitates the real-time monitoring of these reactions even in the presence of potentially interfering chromophores …”
Section: Introductionmentioning
confidence: 99%
“…32,33 The red-shifted absorption and visible-range emission of such fluorescent substrate surrogates opens a spectral window not accessible by other means, which facilitates the real-time monitoring of these reactions even in the presence of potentially interfering chromophores. 34 Applying such approaches to nucleobase-processing enzymes such as human GDA represents, however, a minimally explored territory, as highly emissive nucleobase analogs have not been broadly tested and scrutinized as substrates. 6,13 The lack of the rather large and contact forming D-ribose residue presents the challenge of altering guanine without disturbing contacts at the active site of such a potentially fastidious nucleobase-processing enzyme.…”
Section: ■ Introductionmentioning
confidence: 99%